Dr. Fogel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30795 23 Mile Rd
Suite 206
Chesterfield, MI 48047Phone+1 586-598-5731Fax+1 586-948-1530
Education & Training
University of California (San Francisco)Fellowship, Gastroenterology, 1977 - 1979- University of California (San Francisco)Residency, Internal Medicine, 1977 - 1978
McGill University Faculty of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 1976 - Present
MI State Medical License 1990 - 2027
IN State Medical License 1984 - 1991- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (AGAF) American Gastroenterological Association, 2006
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
- 12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsLong-Term Treatment of Eosinophilic Esophagitis With Budesonide Oral Suspension.Evan S. Dellon, Margaret H. Collins, David A. Katzka, Vincent A. Mukkada, Gary W. Falk
Clinical Gastroenterology and Hepatology. 2021-06-26 - 37 citationsThe economic impact of irritable bowel syndrome in a managed care setting.Rosalie P. Patel, Antonio Petitta, Ronald Fogel, Edward L. Peterson, Barbara J. Zarowitz
Journal of Clinical Gastroenterology. 2002-07-01 - 45 citationsEffects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative ColitisSilvio Danese, Markus F. Neurath, Adam Kopon, Salam F. Zakko, Timothy C. Simmons
Clinical Gastroenterology and Hepatology. 2020-10-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
